MMSI · NASDAQ · STOCK
Merit Medical Systems (MMSI) Stock Analysis
$87.20
52W $59.74 – $94.75
63/100
$5.21B
35.6
0.51
Is MMSI Bullish or Bearish?
Bullish.
Innellis AI committee rates Merit Medical Systems, Inc. (MMSI) Buy with a composite score of 63/100
, based on 6 analysts with 67% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +11.83 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -8.17 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — 4 consecutive earnings beats -- consistent execution. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- News sentiment is positive (+0.20 across 16 articles, 14d) — News
Bear Case
- P/E of 35.7 is moderate-to-rich — Value
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
63/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 12%
of 192 Healthcare peers
Value Analyst
neutral
55
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 35.7 is moderate-to-rich
Growth Analyst
bullish
77
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst
bullish
70
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 16 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 63.6 to 63.2.
- New bearish signals: 1 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
57.1
Neutral
MACD Histogram
-0.095
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$86.14
Resistance
$90.00
Bollinger %B
0.72
Inside Bands
Price vs Moving Averages
EMA 9
$86.15
Above
EMA 21
$86.53
Above
EMA 50
$85.18
Above
EMA 200
$80.34
Above
Fundamental Analysis
Valuation
52
Growth
88
Profitability
52
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
35.6×
P/B Ratio
3.10×
PEG Ratio
1.72
Dividend Yield
0.00%
52W High
$94.75
52W Low
$59.74
Quality & Growth
ROE
811.0%
ROA
478.4%
Gross Margin
4951.5%
Operating Margin
1275.1%
Revenue Growth YoY
—
Debt / Equity
0.49
AI Fundamental Assessment
P/E ratio of 35.6 (rich relative to a 15-40x range); Price-to-book of 3.1x; PEG ratio of 1.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 8.1%; Return on assets of 4.8%; Net margin of 9.2%; Gross margin of 49.5%; Current ratio of 4.20 (healthy short-term liquidity); Debt-to-equity of 0.49; Free cash flow per share is positive (3.41); Most recent quarter beat estimates by 21.7%; 4 consecutive earnings beats; EPS growth accelerating (-9.6% -> +26.6% QoQ); Analyst estimates flat over recent quarters
Get the Full MMSI Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →